UpCard-CA1 is an advanced veterinary diuretic engineered to combat
pulmonary edema in dogs suffering from congestive heart failure due to
myxomatous mitral valve disease (MMVD). This FDA conditionally approved
medication provides a targeted, once-daily treatment solution with
precise oral dosing to support canine cardiac management.

▪Specialized loop diuretic for dogs with MMVD-related heart failure
▪Precise oral solution allowing accurate dosage adjustments
▪Designed for concurrent use with pimobendan, spironolactone, and ACE
inhibitors
▪Supports respiratory function and reduces pulmonary fluid accumulation
▪Convenient once-daily administration